Android app Apple app link

4D Molecular Therapeutics, Inc. (FDMT) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$7.96
Day's range
$8.82

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
10/01/2026 B.Riley Financial Mayank Mamtani $37.00 $14.31   158.56%
09/14/2026 Cantor Fitzgerald Josh Schimmer $20.00 $13.17   51.86%
11/11/2025 Barclays Gena Wang $33.00 $10.17   224.48%
10/31/2025 Leerink Partners Mani Foroohar $17.00 $11.50   47.84%
10/21/2025 RBC Capital Lisa Walter $26.00 $10.77   141.52%
01/11/2025 Morgan Stanley Judah Frommer $6.00 $5.52   8.7%
09/19/2024 BMO Capital Kostas Biliouris $40.00 $13.28   201.2%
09/19/2024 Loop Capital Markets Geulah Livshits $39.00 $13.31   192.99%
09/19/2024 H.C. Wainwright Matthew Caufield $36.00 $13.31   170.44%
04/15/2024 RBC Capital Lisa Walter $40.00 $26.35   51.8%
04/14/2024 Barclays Gena Wang $45.00 $26.35   70.78%
04/01/2024 Jefferies Nalin Tejavibulya $58.00 $31.86   82.05%
03/28/2024 BMO Capital Kostas Biliouris $63.00 $31.59   99.43%
02/06/2024 BMO Capital Kostas Biliouris $70.00 $30.71   127.98%
07/05/2023 Chardan Capital Geulah Livshits $30.00 $18.43   62.78%

4D Molecular Therapeutics Inc FAQ's

4D Molecular Therapeutics Inc has been rated by research analysts at B.Riley Financial, Cantor Fitzgerald, Goldman Sachs, Barclays, Leerink Partners, RBC Capital in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.